Shein-Chung Chow

Shein-Chung Chow

Professor
Department of Biostatistics and Bioinformatics
Duke University
USA
Tel: 919-668-7523

 
Biography

 Shein-Chung Chow, Ph.D. is currently a Professor at the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina. Prior to joining Duke University, he was the Director of TCOG (Taiwan Cooperative Oncology Group) Statistical Center and the Executive Director of National Clinical Trial Network Coordination Center. Prior to that, Dr. Chow also held various positions in the pharmaceutical industry such as Vice President, Biostatistics, Data Management, and Medical Writing at Millennium Pharmaceuticals, Inc., Cambridge, MA; Executive Director, Statistics and Clinical Programming at Covance, Inc., Director and Department Head at Bristol-Myers Squibb Company, Plansboro, NJ; Senior Statistician and Research Statistician at Parke-Davis Pharmaceutical Division, Warner-Lambert Company, Ann Arbor, MI and Wyeth-Ayerst Laboratories, Rouses Point, NY. Through these positions, Dr. Chow provided technical supervision and guidance to project teams on statistical issues and presentations before partners, regulatory agencies or scientific bodies, defending the appropriateness of statistical methods used in clinical trial design or data analyses or the validity of reported statistical inferences. Dr. Chow identified the best statistical and data management practices, organizes and leads working parties for development of statistical design, analyses and presentation applications, and participated on Data Safety Monitoring Boards in clinical research and development.

 
Research Interest

Shein-Chung Chow research interest includes statistical methodology development and application in the area of biopharmaceutical/clinical statistics such as bioavailability and bioequivalence, clinical trials, bridging studies, medical devices, and translational research/medicine. Most recently, he is interested in statistical methodology development for the use of adaptive design methods in clinical trials and methodology development for assessment of biosimilarity of follow-on biologics. In addition, he is also interested in methodology development for statistical evaluation of traditional Chinese medicine (TCM) clinical trials.

Global Experts in the subject
A Ahmad A Anton Smith A Bhargavi
A Dinakar A Hari Prasad A John Maria Xavier
A K Dinda A Kalaiselvan A P Gadad
A Sarah radloff A Surya Narayana Reddy A. Kottai Muthu
ADNAN MOHAMMED MASSADEH AKBopaiah Aadarsh Choubey
Abbas Akhgari Abdalla Shslaby Abdul Lateef
Abdul Quaiyoom Khan Abdul Rauf Abdur Rub
Abdurrahman Hoser Abhilasha Mittal Abhiranjan Singh
Abhishek Bhatt Abhishiktha S Naik Abhiskek Chatterjee
Abubaker Siddiq Adesola Ogunniyi Adibe Maxwell Ogochukwu
Adigwe Obi Peter Adil Gani Adimule Vinayak
Adinarayana Gorajana Afif Ahmed Agarwal Alka
Agbowuro Ayodeji A Aggarwal Geeta Agnieszka Michael
Agrawal Neeraj Ahmad Ayaz Ahmad Farhan Jalees
Ahmad S Ahmad Sayeed Ahmad Wasim
Ahmed Bahar Ahmed MS Ahmed Ahsan Sunjukta
Ahuja A Aijaz A Sheikh Aisha Siddiqua
Aishwarya Nathan Aishwarya Tandon Ait Hamadouche N
Ajay Kumar Mohapatra Ajay Verma Ajima Ukpe
Ajmera Ankit Akbar Mobinikhaledi Akhilesh Upgade
Akter Asma Alak Kanti Dutta Alam Sanjar
Alfa John Ali Ahmadi-Mirabad Ali Ismail Al Gareeb
Ali Mirza Asif
 
https://wowcappadocia.com
https://cappadocia-hotels.com
https://balloon-rides.net

https://paperio-live.com

rolex replica

https://agario.red

https://naughtyworms.com

Vaporesso
Smok
https://www.unitedluxury.net/